References
- Lloyd-Jones D, Adams RJ, Brown TM, et al.; WRITING GROUP MEMBERS. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46–e215.
- Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477.
- Maron DJ, Hochman JS, Reynolds HR, ISCHEMIA Research Group, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med. 2020;382(15):1395–1407.
- Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS *Guidelines on myocardial revascularization. EuroIntervention. 2019;14(14):1435–1534.
- Udelson JE, Beshansky JR, Ballin DS, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA. 2002;288(21):2693–2700. Erratum in: JAMA 2003 Jan 8;289(2):178.
- Shaw LJ, Cerqueira MD, Brooks MM, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Nucl Cardiol. 2012;19(4):658–669.
- Ortiz-Pérez JT, Rodríguez J, Meyers SN, et al. Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2008;1(3):282–293.
- Faber TL, Santana CA, Garcia EV, et al. Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: clinical validation. J Nucl Med. 2004;45(5):745–753.